Offline
Ranbaxy Laboratories
BSE: 500359 | NSE: RANBAXY | ISIN: INE015A01028 | Pharmaceuticals
| Finished Products | --------------------------- in Rs. Cr. --------------------------- | Dec 2007 | |||
| Product Name | Unit | Installed Capacity |
Production Quantity |
Sales Quantity |
Sales Value |
| Tablets | Millions Numbers | 9,424 | 6,413.29 | 7,901.19 | 2,015.44 |
| Bulk Drugs | Metric Tonnes | 2,001 | 1,547.02 | 1,819.07 | 969.47 |
| Formulation (Capsules) | Millions Numbers | 2,992 | 2,025.27 | 2,291.48 | 613.06 |
| Syrups & Powders Dry | Millions Bottles | 44 | 42.32 | 50.05 | 280.12 |
| Injectible Vials | Millions Numbers | 39 | 35.55 | 103.09 | 253.66 |
| Ointments | - | NA | 317.80 | 983.84 | 133.15 |
| Others | - | NA | NA | NA | 86.68 |
| Liquids | - | NA | 1,372.73 | 3,259.35 | 85.15 |
| Ampoules | Millions Numbers | 48 | 99.47 | 104.37 | 79.47 |
| Other Fiscal Benefits | - | NA | NA | NA | 68.80 |
| Other Operating Income | - | NA | NA | NA | 33.69 |
| Royalty Income | - | NA | NA | NA | 12.72 |
| Drops | - | NA | 46.56 | 46.86 | 7.00 |
| Total | 4,638.41 | ||||
 | |||||
| Source : Asian CERC | |||||
| |||||
